China SXT Pharmaceuticals, Inc.
SXTC· Nasdaq
China SXT Pharmaceuticals, Inc.
- Last sale
- Oct 2, 2026 · -25.08%
- Market cap
- $2.20M
- 958.08K shares
- Filings
- 163
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-31 | $1,138,052 | reported | |
| FY 2025 | 2025-03-31 | $1,740,907 | reported | |
| FY 2024 | 2024-03-31 | $1,928,497 | reported | |
| FY 2023 | 2023-03-31 | $1,971,679 | reported | |
| FY 2022 | 2022-03-31 | $2,602,281 | reported | |
| FY 2021 | 2021-03-31 | $4,777,573 | reported | |
| FY 2020 | 2020-03-31 | $5,162,268 | reported | |
| FY 2019 | 2019-03-31 | $7,012,026 | reported | |
| FY 2018 | 2018-03-31 | $7,019,243 | reported | |
| FY 2017 | 2017-03-31 | $4,881,523 | reported |
China SXT Pharmaceuticals, Inc. · CIK 1723980 · Engraved from SEC EDGAR
